A recombinant pseudorabies virus expressing rabies virus glycoprotein: Safety and immunogenicity in dogs

Vaccine

Volumn 26, Issue 10, 2008, Pages 1314-1321

  Yuan, Ziguo ^a,b   Zhang, Shoufeng ^a   Liu, Ye ^a   Zhang, Fei ^a   Fooks, Anthony R ^c   Li, Qianxue ^d   Hu, Rongliang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b JILIN UNIVERSITY   (China)

^c VETERINARY LABORATORIES AGENCY   (United Kingdom)

^d NONE

Author keywords

Dogs; Oral vaccination; Rabies virus glycoprotein; Recombinant pseudorabies virus

Indexed keywords

KENNEL COUGH VACCINE; NEUTRALIZING ANTIBODY; PSEUDORABIES VACCINE; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DOG; IMMUNE RESPONSE; IMMUNOGENICITY; IN VIVO STUDY; INOCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDORABIES; PSEUDORABIES HERPETOVIRUS; RABIES; RABIES VIRUS; SAFETY; VACCINATION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CELL LINE; CERCOPITHECUS AETHIOPS; DNA, VIRAL; DOG DISEASES; DOGS; FLOW CYTOMETRY; GLYCOPROTEINS; HERPESVIRUS 1, SUID; NEUTRALIZATION TESTS; PSEUDORABIES; PSEUDORABIES VACCINES; RABIES VIRUS; VACCINATION; VACCINES, SYNTHETIC; VERO CELLS;

EID: 39249083194     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.12.050     Document Type: Article

References (26)

1. Tordo N., Bahloul C., Jacob Y., Jallet C., Perrin P., and Badrane H. Rabies: epidemiological tendencies and control tools. Dev Biol (Basel) 125 (2006) 3-13
2. Dietzschold B., Faber M., and Schnell M.J. New approaches to the prevention and eradication of rabies. Expert Rev Vaccines 2 (2003) 399-406
3. Hu R.L., Zhang S.F., Fooks A.R., Yuan H.J., Liu Y., Li H.T., et al. Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein. Microbes Infect 8 4 (2006) 1090-1097
4. Prehaud C., Takehara K., Flamand A., and Bishop D.H. Immunogenic and protective properties of rabies virus glycoprotein expressed by baculovirus vectors. Virology 173 (1989) 390-399
5. Prevec L., Campbell J.B., Christie B.S., Belbeck L., and Graham F.L. A recombinant human adenovirus vaccine against rabies. J Infect Dis 161 (1990) 27-30
6. McKenna P.M., McGettigan J.P., Pomerantz R.J., Dietzschold B., and Schnell M.J. Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases. Curr HIV Res 1 2 (2003) 229-237
7. Rupprecht C.E., Hanlon C.A., Blanton J., Manangan J., Morrill P., Murphy S., et al. Oral vaccination of dogs with recombinant rabies virus vaccines. Virus Res 111 1 (2005) 101-105
8. Qian P., Li X.M., Jin M.L., Peng G.Q., and Chen H.C. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine. Vaccine 22 17-18 (2004) 2129-2136
9. Klupp B.G., Hengartner C.J., Mettenleiter T.C., and Enquist L.W. Complete, annotated sequence of the pseudorabies virus genome. J Virol 78 (2004) 424-440
10. Olsen L.M., Ch'ng T.H., Card J.P., and Enquist L.W. Role of pseudorabies virus US3 protein kinase during neuronal infection. J Virol 80 (2006) 6387-6398
11. Kimman T.G., de Wind N., Oei-Lie N., Pol J.M., Berns A.J., and Gielkens A.L. Contribution of single genes within the unique short region of Aujeszky's disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity. J Gen Virol 73 Pt 2 (1992) 243-251
12. Xu G.X., Xu X.J., Li Z.L., He Q.G., Wu B., Sun S.F., et al. Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity. Vaccine 22 (2004) 1846-1853
13. In: Wiktor T.J. (Ed). Laboratory techniques in rabies: tissue culture methods. Monogr Ser World Health Org (1973) 101-123
14. Ju C.M., Fan H.Y., Tan Y.D., Liu Z.F., Xi X., Cao S.B., et al. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2. Vet Microbiol 109 3-4 (2005) 179-190
15. Bordignon J., Pires Ferreira S.C., Medeiros Caporale G.M., Carrieri M.L., Kotait I., Lima H.C., et al. Flow cytometry assay for intracellular rabies virus detection. J Virol Methods 105 1 (2002) 181-186
16. Hu R.L., Liu Y., Zhang S.F., Zhang F., and Fooks A.R. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies. Vaccine 25 29 (2007) 5301-5307
17. Jiang Y.B., Fang L.R., Xiao S.B., Zhang H., Pan Y.F., Luo R., et al. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus. Vaccine 25 3 (2007) 547-560
18. Olding-Stenkvist E., Nordbring F., Larsson E., Lindblom B., and Wigzell H. Fatal progressive vaccinia in two immunodeficient infants. Scand J Infect Dis Suppl. 24 (1980) 63-67
19. Aoletti E., Tartaglia J., and Taylor J. Safe and effective poxvirus vectors-NYVAC and ALVAC. Dev Biol Stand 82 (1994) 65-69
20. Yarosh O.K., Wandeler A.I., Graham F.L., Campbell J.B., and Prevec L. Human adenovirus type 5 vectors expressing rabies glycoprotein. Vaccine 14 13 (1996) 1257-1264
21. Appel M., Carmichael L.E., and Robson D.S. Canine adenovirus type 2-induced immunity to two canine adenoviruses in pups with maternal antibody. Am J Vet Res 36 (1975) 1199-1202
22. Papp Z., Babiuk L.A., and Baca-Estrada M.E. The effect of pre-existing adenovirus-specific immunity on immune responses induced by recombinant adenovirus expressing glycoprotein D of bovine herpesvirus type 1. Vaccine 17 (1999) 933-943
23. Hong Q., Qian P., Li X.M., Yu X.L., and Chen H.C. A recombinant pseudorabies virus co-expressing capsid proteins precursor P1-2A of FMDV and VP2 protein of porcine parvovirus: a trivalent vaccine candidate. Biotechnol Lett 29 11 (2007) 1677-1683
24. Ferrari M., Brack A., Romanelli M.G., Mettenleiter T.C., Corradi A., Dal Mas N., et al. A study of the ability of a TK-negative and gI/gE-negative pseudorabies virus (PRV) mutant inoculated by different routes to protect pigs against PRV infection. J Vet Med B: Infect Dis Vet Public Health 47 10 (2000) 753-762
25. Yin J., Ren X., Tian Z., and Li Y. Assembly of pseudorabies virus genome-based transfer vehicle carrying major antigen sites of S gene of transmissible gastroenteritis virus: potential perspective for developing live vector vaccines. Biologicals 35 1 (2007) 55-61
26. Tian Z.J., Zhou G.H., Zheng B.L., Qiu H.J., Ni J.Q., Yang H.L., et al. A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge. Vet Immunol Immunopathol 111 3-4 (2006) 211-218